Propagation of undifferentiated human embryonic stem cells with nano-liposomal ceramide
- PMID: 18393629
- DOI: 10.1089/scd.2007.0271
Propagation of undifferentiated human embryonic stem cells with nano-liposomal ceramide
Abstract
Human embryonic stem (hES) cells, located on the periphery of the colonies, express the neuroectodermal markers nestin and Tuj1, suggesting a prematurely differentiated subgroup of cells. Here, we report that ceramide, a bioactive sphingolipid, selectively eliminates hES cells differentially expressing nestin and Tuj1. In contrast, undifferentiated cells are resistant to the apoptotic effects of ceramide. Ceramide-resistant hES cells express higher levels of the messenger RNA for ceramide-metabolizing enzymes that convert ceramide into pro-mitogenic metabolites. Based on these findings, we conducted long-term studies to determine whether liposomal ceramide can be used to maintain undifferentiated hES cells free of feeder cells. We continuously cultured hES cells on matrigel for 4 months with liposomal ceramide in a feeder cell-free system. Human ES cells treated with liposomal ceramide maintained their pluripotent state as determined by in vivo and in vitro differentiation studies and contained no chromosomal abnormalities. In conclusion, our findings suggest that exposure to ceramide provides a viable strategy to prevent premature hES cell differentiation and to maintain pluripotent stem cell populations in the absence of feeder cells.
Similar articles
-
Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants.J Cell Biol. 2004 Nov 22;167(4):723-34. doi: 10.1083/jcb.200405144. Epub 2004 Nov 15. J Cell Biol. 2004. PMID: 15545317 Free PMC article.
-
A chimeric vitronectin: IGF-I protein supports feeder-cell-free and serum-free culture of human embryonic stem cells.Stem Cells Dev. 2010 Sep;19(9):1297-305. doi: 10.1089/scd.2009.0504. Stem Cells Dev. 2010. Retraction in: Stem Cells Dev. 2013 Feb 15;22(4):687. doi: 10.1089/scd.2012.0706. PMID: 20128657 Retracted.
-
A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo.Brain Res. 2007 Jan 5;1127(1):19-25. doi: 10.1016/j.brainres.2006.10.022. Epub 2006 Nov 21. Brain Res. 2007. PMID: 17123482 Free PMC article.
-
Embryonic stem cells.Stem Cells Dev. 2007 Apr;16(2):213-22. doi: 10.1089/scd.2006.0081. Stem Cells Dev. 2007. PMID: 17521233 Review.
-
Identification of small molecules from human embryonic stem cells using metabolomics.Stem Cells Dev. 2007 Dec;16(6):869-82. doi: 10.1089/scd.2007.0022. Stem Cells Dev. 2007. PMID: 18042039 Review.
Cited by
-
Sphingolipids and expression regulation of genes in cancer.Prog Lipid Res. 2011 Jan;50(1):104-14. doi: 10.1016/j.plipres.2010.10.003. Epub 2010 Oct 21. Prog Lipid Res. 2011. PMID: 20970453 Free PMC article. Review.
-
Ceramide and S1P Signaling in Embryonic Stem Cell Differentiation.Methods Mol Biol. 2018;1697:153-171. doi: 10.1007/7651_2017_43. Methods Mol Biol. 2018. PMID: 28540559 Free PMC article.
-
Innovation in the culture and derivation of pluripotent human stem cells.Curr Opin Biotechnol. 2008 Oct;19(5):527-33. doi: 10.1016/j.copbio.2008.08.005. Epub 2008 Sep 15. Curr Opin Biotechnol. 2008. PMID: 18760357 Free PMC article. Review.
-
Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Adv Cancer Res. 2013;117:59-89. doi: 10.1016/B978-0-12-394274-6.00003-0. Adv Cancer Res. 2013. PMID: 23290777 Free PMC article. Review.
-
Development of Scalable Culture Systems for Human Embryonic Stem Cells.Biochem Eng J. 2010 Feb 15;48(3):378. doi: 10.1016/j.bej.2009.10.020. Biochem Eng J. 2010. PMID: 20161686 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
